INSP Stock Overview
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for INSP from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Inspire Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$159.81 |
| 52 Week High | US$257.40 |
| 52 Week Low | US$123.00 |
| Beta | 1.39 |
| 1 Month Change | 0.16% |
| 3 Month Change | -17.41% |
| 1 Year Change | -36.00% |
| 3 Year Change | -8.00% |
| 5 Year Change | 123.70% |
| Change since IPO | 539.75% |
Recent News & Updates
Should You Investigate Inspire Medical Systems, Inc. (NYSE:INSP) At US$160?
Apr 30
Investors Appear Satisfied With Inspire Medical Systems, Inc.'s (NYSE:INSP) Prospects
Mar 25Inspire Medical Systems: Fine Company, Stretched Valuations And Slowing Growth
Mar 18Recent updates
Should You Investigate Inspire Medical Systems, Inc. (NYSE:INSP) At US$160?
Apr 30Investors Appear Satisfied With Inspire Medical Systems, Inc.'s (NYSE:INSP) Prospects
Mar 25Inspire Medical Systems: Fine Company, Stretched Valuations And Slowing Growth
Mar 18Inspire Medical Systems, Inc.'s (NYSE:INSP) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 07Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up
Jan 21Getting In Cheap On Inspire Medical Systems, Inc. (NYSE:INSP) Might Be Difficult
Dec 11Inspire Medical Systems: Getting Cheaper But Not There Yet
Nov 23Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03
Expanding US Presence And European Approval Set To Skyrocket Neurostimulation Market Share
Aug 29 Expansion into new U.S. implanted centers and sales territories, alongside EU product certifications, expected to significantly boost domestic and international revenues.After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors
Dec 26Inspire Medical Systems: Time To Wake Up
Nov 17An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued
Nov 13Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?
Sep 05Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?
Aug 10Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing
Jul 16Shareholder Returns
| INSP | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.5% | 1.5% | 2.9% |
| 1Y | -36.0% | 8.3% | 10.0% |
Return vs Industry: INSP underperformed the US Medical Equipment industry which returned 6.3% over the past year.
Return vs Market: INSP underperformed the US Market which returned 9.5% over the past year.
Price Volatility
| INSP volatility | |
|---|---|
| INSP Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: INSP has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: INSP's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,246 | Tim Herbert | www.inspiresleep.com |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
Inspire Medical Systems, Inc. Fundamentals Summary
| INSP fundamental statistics | |
|---|---|
| Market cap | US$4.70b |
| Earnings (TTM) | US$53.51m |
| Revenue (TTM) | US$802.80m |
88.9x
P/E Ratio5.9x
P/S RatioIs INSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INSP income statement (TTM) | |
|---|---|
| Revenue | US$802.80m |
| Cost of Revenue | US$122.99m |
| Gross Profit | US$679.82m |
| Other Expenses | US$626.31m |
| Earnings | US$53.51m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 05, 2025
| Earnings per share (EPS) | 1.80 |
| Gross Margin | 84.68% |
| Net Profit Margin | 6.67% |
| Debt/Equity Ratio | 0% |
How did INSP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 05:42 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Inspire Medical Systems, Inc. is covered by 24 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| David Rescott | Baird |
| Ravi Misra | Berenberg |